The most commonly reported variant in ASXL1 (c.1934dupG;p.Gly646TrpfsX12) is not a somatic alteration

Eitemau Tebyg

• ASXL1 c.1934dup;p.Gly646Trpfs*12—a true somatic alteration requiring a new approach
  gan: Yannakou, Costas K., et al.
  Cyhoeddwyd: (2017)
• Clinical molecular testing for ASXL1 c.1934dupG p.Gly646fs mutation in hematologic neoplasms in the NGS era
  gan: Montes-Moreno, Santiago, et al.
  Cyhoeddwyd: (2018)
• The ASXL1 mutation p.Gly646Trpfs*12 found in a Turkish boy with Bohring‐Opitz Syndrome
  gan: Urreizti, Roser, et al.
  Cyhoeddwyd: (2018)
• The ASXL1 mutation p.Gly646Trpfs*12 found in a Turkish boy with Bohring‐Opitz Syndrome
  gan: Roser Urreizti, et al.
  Cyhoeddwyd: (2018-08-01)
• Discriminating a common somatic ASXL1 mutation (c.1934dup; p.G646Wfs*12) from artifact in myeloid malignancies using NGS
  gan: Alberti, Michael O., et al.
  Cyhoeddwyd: (2018)